Vanguard Group Inc Relay Therapeutics, Inc. Transaction History
Vanguard Group Inc
- $5.12 Trillion
- Q2 2024
A detailed history of Vanguard Group Inc transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 11,704,866 shares of RLAY stock, worth $87.2 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
11,704,866
Previous 11,815,669
0.94%
Holding current value
$87.2 Million
Previous $98.1 Million
22.18%
% of portfolio
0.0%
Previous 0.0%
Shares
13 transactions
Others Institutions Holding RLAY
# of Institutions
182Shares Held
126MCall Options Held
1.7KPut Options Held
18K-
Sb Investment Advisers (Uk) LTD London, X027.9MShares$208 Million1.68% of portfolio
-
Black Rock Inc. New York, NY10.5MShares$78.5 Million0.0% of portfolio
-
Casdin Capital, LLC New York, NY8.45MShares$62.9 Million4.77% of portfolio
-
Bellevue Group Ag Kuesnacht, V86.38MShares$47.5 Million0.7% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD5.04MShares$37.5 Million0.0% of portfolio
About Relay Therapeutics, Inc.
- Ticker RLAY
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 120,219,000
- Market Cap $896M
- Description
- Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...